Pantel, K; Andersen, CL; Schuuring, E; Malats, N; Heitzer, E; Vat, L; Kiernan, E; Chin, E; Barrett, C; Kapp, R; Thomas, M; Gerling, M; Reck, M; Löhr, M; Hofman, P; Hiltermann, N; Alix-Panabières, C; Smit, J; Bolisetty, M; Karasarides, M.
GUIDE.MRD: A Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA) in clinical practice to improve patient outcomes
ANN ONCOL. 2023; 34: S276-S277.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN.
Doi: 10.1016/j.annonc.2023.09.2960
[Poster]
Web of Science
FullText
FullText_MUG